Iman Imanirad

CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

Comparison of AI-generated radiology impressions: a multi-stakeholder evaluation.

Journal: NPJ digital medicine

Published: December 30, 2025

Cardiac Septal Metastasis From Poorly Differentiated Colorectal Adenocarcinoma: A Rare Case Illustrating the Role of Multimodal Imaging and Multidisciplinary Management.

Journal: Case reports in cardiology

Published: August 11, 2025

Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

Journal: Cancers

Published: April 16, 2025

Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis.

Journal: Journal of surgical oncology

Published: November 16, 2024

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.

Journal: Clinical pharmacology and therapeutics

Published: October 21, 2024

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral.

Journal: JCO oncology practice

Published: October 17, 2024

Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566.

Journal: Cancers

Published: October 01, 2024

The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct.

Journal: Annals of surgical oncology

Published: August 22, 2024

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.

Journal: British journal of cancer

Published: May 04, 2024

Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: April 08, 2024

CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.

CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.

CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.

CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.

Comparison of AI-generated radiology impressions: a multi-stakeholder evaluation.

Comparison of AI-generated radiology impressions: a multi-stakeholder evaluation.

Cardiac Septal Metastasis From Poorly Differentiated Colorectal Adenocarcinoma: A Rare Case Illustrating the Role of Multimodal Imaging and Multidisciplinary Management.

Cardiac Septal Metastasis From Poorly Differentiated Colorectal Adenocarcinoma: A Rare Case Illustrating the Role of Multimodal Imaging and Multidisciplinary Management.

Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis.

Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis.

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral.

Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566.

Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566.

The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct.

The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct.

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.

Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors.

Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors.

Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis.

Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis.